Abstract
Current Pharmaceutical Design
Title: Editorial [Hot Topic: DNA Anti-Cancer Drug Design (Executive Editor: Naijie Jing)]
Volume: 11 Issue: 22
Author(s): Naijie Jing
Affiliation:
Abstract:
Export Options
About this article
Cite this article as:
Jing Naijie, Editorial [Hot Topic: DNA Anti-Cancer Drug Design (Executive Editor: Naijie Jing)], Current Pharmaceutical Design 2005; 11 (22) . https://dx.doi.org/10.2174/1381612054546734
DOI https://dx.doi.org/10.2174/1381612054546734 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
13
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Screening for Infectious Diseases During Pregnancy: Which Test and Which Situation
Current Women`s Health Reviews Targeting Aurora Kinases: A Novel Approach to Curb the Growth & Chemoresistance of Androgen Refractory Prostate Cancer
Current Cancer Drug Targets Menthol – Pharmacology of an Important Naturally Medicinal “Cool”
Mini-Reviews in Medicinal Chemistry Synthesis and Antitumor/Antiviral Evaluation of 6–Thienyl–5–cyano-2–thiouracil Derivatives and Their Thiogalactosides Analogs
Current Organic Synthesis Kaempferol Improves TRAIL-Mediated Apoptosis in Leukemia MOLT-4 Cells by the Inhibition of Anti-apoptotic Proteins and Promotion of Death Receptors Expression
Anti-Cancer Agents in Medicinal Chemistry A Comprehensive Review on the Genetic Regulation of Cisplatin-induced Nephrotoxicity
Current Genomics An Integrative Analysis of the Putative Gefitinib-resistance Related Genes in a Lung Cancer Cell Line Model System
Current Cancer Drug Targets EZH2 RIP-seq Identifies Tissue-specific Long Non-coding RNAs
Current Gene Therapy LncRNA HOTAIR Polymorphisms Association with Cancer Susceptibility in Different Tumor Types
Current Drug Targets Combination of Multifunctional Nanoparticles and Interventional Techniques Makes Each Other Going Further in the Field of Cancer Treatment
Current Drug Metabolism Antimicrobial Photosensitizers: Drug Discovery Under the Spotlight
Current Medicinal Chemistry Recent Advances in Elucidating Paclitaxel Resistance Mechanisms in Non-small Cell Lung Cancer and Strategies to Overcome Drug Resistance
Current Medicinal Chemistry Recent Clinical Trials of mTOR-Targeted Cancer Therapies
Reviews on Recent Clinical Trials Delivery of Bioactive Peptides and Proteins Across Oral (Buccal) Mucosa
Current Pharmaceutical Biotechnology Post-locoregional Therapy MRI Evaluation of Malignant Liver Lesions
Current Cancer Therapy Reviews Multi-Target Mining of Alzheimer Disease Proteome with Hansch’s QSBR-Perturbation Theory and Experimental-Theoretic Study of New Thiophene Isosters of Rasagiline
Current Drug Targets Chemically Modified Nano Crystalline Diamond Layer as Material Enhanced Laser Desorption Ionisation (MELDI) Surface in Protein Profiling
Current Nanoscience ADAM9 as a Potential Target Molecule in Cancer
Current Pharmaceutical Design Anti-Cancer/Anti-Tumor
Current Bioactive Compounds Anticancer Drug Discovery Targeting DNA Hypermethylation
Current Medicinal Chemistry